• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

President Slashes NIH Funding by 13 percent
The National Institutes of Health (NIH) would receive $34.4 billion in FY 2020, roughly $4.7 billion or 13 percent below the levels enacted by Congress for FY 2019, according to the President’s Budget released on March 11. The budget for NIH includes $492 million in funding made available through the 21st Century Cures Act and $150 million in mandatory funding. The leading biomedical research agency in the world would receive budget cuts across the board. All NIH centers are slated for budget reductions: National Cancer Institute: -8.7 percent National Heart, Lung, and Blood Institute: -14 percent National Inst...
Source: Public Policy Reports - March 19, 2019 Category: Biology Authors: AIBS Source Type: news

Mind the Treatment Gap
getty images/ istock photoBy Vani S. Kulkarni and Raghav GaihaPHILADELPHIA AND NEW DELHI, Apr 14 2017 (IPS)Implementation of the Mental Healthcare Act will require a restructuring of health-care services The Mental Healthcare Bill, 2016, which was passed in the Lok Sabha on March 27, 2017, has been hailed as a momentous reform. According to the Bill, every person will have the right to access mental health care operated or funded by the government; good quality and affordable health care; equality of treatment and protection from inhuman practices; access to legal services; and right to complain against coercion and cruelt...
Source: IPS Inter Press Service - Health - April 14, 2017 Category: Global & Universal Authors: Vani Kulkarni and Raghav Gaiha Tags: Asia-Pacific Development & Aid Gender Gender Violence Headlines Health Human Rights Women's Health Source Type: news

Tau Imaging Among Breakthroughs Advancing the Fight against Alzheimer ' s
Worldwide,  nearly44 million  people now have Alzheimer ' s disease (AD) or related dementia, making these conditions the  top cause of disabilities in later life. The biopharma industry has invested billions of dollars into research to treat and prevent AD1, yet this work has faced many obstacles, including difficulty identifying biomarkers, tracking the disease ’s progress in the brain, and recruiting patients to trials while they are still asymptomatic. But in recent years, we’ve begun to see breakthroughs that is driving our research in new directions. Many of these accomplishments were highlighted at the Alzh...
Source: EyeForPharma - September 21, 2016 Category: Pharmaceuticals Authors: Olga Uspenskaya-Cadoz Source Type: news

ACR Preliminary Summary of Radiology Provisions in the 2017 MPFS Proposed Rule
The Centers for Medicare and Medicaid Services (CMS) released the Medicare Physician Fee Schedule (MPFS) proposed rule on Thursday, July 7. Upon initial review, the American College of Radiology (ACR) is pleased with several provisions within the rule. CMS has recognized the value provided by radiologists in providing mammography services through an increase in the physician work relative value units (RVUs) for diagnostic mammography and maintaining the current value for screening mammography. Additionally, ACR physicians and staff held numerous conference calls and meetings with CMS on the topic of appropriate use criteri...
Source: American College of Radiology - July 8, 2016 Category: Radiology Source Type: news

Budget Impact Analysis of Botulinum Toxin A Therapy For Upper Limb Spasticity In Hong Kong
Upper limb spasticity (ULS) secondary to stroke has a considerable patient and caregiver burden, particularly with regards to pain, activities of daily living and mobility. Botulinum neurotoxin-A (BoNT-A) injections are effective in treating ULS. We aimed to calculate annual cost per-patient basis and the expected overall annual budget impact in Hong Kong using static and dynamic market share scenarios.
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: J. Dinet, E. Nai Mo LAM, S. Gabriel Source Type: research

Budget Impact Analysis Of Botulinum Toxin A Therapy For Upper Limb Spasticity In Germany
Upper limb spasticity (ULS) secondary to stroke has a considerable patient and caregiver burden, particularly with regards to pain, activities of daily living and mobility. Botulinum neurotoxin-A (BoNT-A) injections are effective in treating ULS. We aimed to calculate annual BoNT-A treatment cost of ULS on a per-patient basis, and the expected overall annual budget impact of BoNT-A treatment in Germany using static and dynamic market share scenarios.
Source: Value in Health - November 1, 2014 Category: Global & Universal Authors: Y.F. Zoellner, M. Gerwe, M. Richter Source Type: research